The day after the announcement from the Canadian Life and Health Insurance Association (CLHIA) about a new pooling framework for high-cost drugs, Stephen Frank, vice-president of policy development and health, spoke at a seminar releasing further details of the plan.
A group of 23 Canadian insurance companies has come up with a plan to share the cost of high-priced drug treatments—a move they say will protect Canadians from the risk of losing their employer-sponsored coverage due to a big claim.
On March 27, the Ontario government tabled its new fiscal budget—and it includes a number of long-term initiatives that will have a significant impact on the health plans of Ontario employers in the coming years.
The growing impact of high-cost specialty drugs, coupled with shifting roles for health practitioners, calls for stakeholders to work together to improve drug plan efficiencies. But how?
Magna International Inc., a global vehicle part manufacturer and assembler with a workforce of 104,000, has a decentralized management structure that allows every division to run as a separate entity, said Arthur Fabbro, the organization’s director of total compensation.
Barbara Martinez, a principal with Mercer, reported on the findings of the organization’s 2011 survey of Canadian private drug plans.
Less than 20% of plan sponsors are capable of tracking their specialty drug spend, according to a survey by the U.S.-based Pharmacy Benefit Management Institute (PBMI).
Steve Moffatt, senior vice-president of sales and marketing with Green Shield Canada, questioned plan sponsors’ ongoing tendency to have their drug plans provide full coverage in today’s financially constrained landscape.
Equitable Life of Canada has launched a new drug plan management tool kit, designed to help employers to better understand their drug plan risks and implement solutions to those risks.
Five years ago, Halifax Professional Firefighters took a big step with their benefits plan when they chose to begin actively managing the plan themselves.